Redifferentiation of a BRAF K601E -Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Thyroid Année : 2019

Redifferentiation of a BRAF K601E -Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-03101244 , version 1 (07-01-2021)

Identifiants

Citer

Sophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, Marie Attard, Serena Grimaldi, et al.. Redifferentiation of a BRAF K601E -Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib Treatment. Thyroid, 2019, 29 (5), pp.735-742. ⟨10.1089/thy.2018.0457⟩. ⟨hal-03101244⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More